Secondary Glaucoma Associated With Orbital Pseudotumor
DOI:
https://doi.org/10.63682/jns.v14i25S.6114Keywords:
Orbital pseudotumor, glaucoma, trabeculectomyAbstract
Orbital pseudotumor is a non-infectious and benign inflammatory condition of the orbit and the surrounding tissues. This case report aims to emphasize the importance of understanding the cause-effect relationship between orbital inflammation and raised intraocular pressure (IOP). An 18-year-old girl was previously diagnosed with primary angle-closure glaucoma and had a history of twice trabeculectomy surgeries done elsewhere two months before she came to our hospital. She came with left eye pain, eyelid edema, ptosis, conjunctival chemosis, ophthalmoplegia, and elevated IOP despite a positive seidel test for a leaking trabeculectomy bleb. Five months prior to her first surgery she realized an inward squint on her left eye. She also felt joint pain for a year before the ophthalmic symptoms. After comprehensive diagnostics, she was diagnosed with left eye orbital pseudotumor and secondary glaucoma with spondyloarthropathy. Daily 30 mg of oral prednisone was given to reduce the inflammation. After a week, her conditions improved with decreased IOP although there was no additional anti-glaucoma medication. The raised IOP in orbital pseudotumor is often caused by the swelling of orbital tissue and extraocular muscles, that result in choroidal circulation problems from the superior and inferior ophthalmic veins compression. The IOP was greatly reduced once the inflammation was treated Diagnosing orbital pseudotumor may be challenging since it can mimic various conditions. Secondary glaucoma should be acknowledged as a complication in patients with orbital pseudotumor. Once orbital pseudotumor is diagnosed, a systemic steroid should be given to manage the inflammatory conditions as well as resultant glaucoma.
Downloads
Metrics
References
Karcioglu ZA. Mass-Forming Inflammatory Lesions of the Orbit. In: Karcioglu ZA, editor. Orbital Tumors: Diagnosis and Treatment. New Orleans, LA: Springer; 2005. p. 335-52.
Sato Y, Mano N, Watanabe H, Miyamoto M, Shimizu K, Mukai N, et al. A Case of Idiopathic Orbital Inflammation with Shallow Anterior Chamber and Choroidal Detachment. Case Reports in Ophthalmology. 2020;11:8-15.
Ronquillo Y, Pate BC. Nonspecific Orbital Inflammation. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551576/.
Brar GK, Krishn JS, Gupta N, Prabha A, Phutela P, Chadha C. Non specific orbital inflammatory disease – A review article. IP International Journal of Ocular Oncology and Oculoplasty. 2022;8:115-9.
Lee NC, Loyal J, Berkwitt A. More Than Meets the Eye: Idiopathic Orbital Inflammation Mimicking Orbital Cellulitis. Cureus. 2021;13.
Spindle J, Tang SX, Davies B, Wladis EJ, Piozzi E, Pellegrini M, et al. Pediatric Idiopathic Orbital Inflammation: Clinical Features of 30 Cases. Ophthalmic plastic and reconstructive surgery. 2016;32(4):270-4.
Yeşiltaş YS, Gündüz AK. Idiopathic Orbital Inflammation: Review of Literature and New Advances. Middle East Afr J Ophthalmol. 2018;25(2):71-80.
Eshraghi B, Sonbolestan SA, Abtahi M-A, Mirmohammadsadeghic A. Clinical characteristics, histopathology, and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation. Journal of Current Ophthalmology. 2019;31:327-34.
The American Academy of Ophthalmology. Orbital Inflammatory and Infectious Disorders. BCSC Section 4, Ophthalmic Pathology and Intraocular Tumors. San Francisco, CA: American Academy of Ophthalmology; 2020. p. 43-67.
Demirci H. Idiopathic Orbital Inflammation. In: Demirci H, editor. Orbital Inflammatory Diseases and Their Differential Diagnosis Essentials in Ophthalmology. Berlin: Springer; 2015.
Jirawuthiworavong GV, M.A. RVC, Lee AG, Al-Zubidi N, Yen MT, Marcet MM, et al. Nonspecific Orbital Inflammation (Idiopathic Orbital Inflammation, Orbital Inflammatory Syndrome, Orbital Pseudotumor)2022. Available from: https://eyewiki.aao.org/Nonspecific_Orbital_Inflammation_(Idiopathic_Orbital_Inflammation,_Orbital_Inflammatory_Syndrome,_Orbital_Pseudotumor).
Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Progress in Retinal and Eye Research. 2021;83.
Okeke CO. Address inflammation in glaucoma. Ophthalmology Management. 2018;22(August 2018):44-6.
Nassr MA, Morris CL, Netland PA, Karcioglu ZA. Intraocular Pressure Change in Orbital Disease. Survey of Ophthalmology. 2009;54(5).
Otsuka M, Yunoki T, Ozaki H, Hayashi A. Clinical Characteristics of Idiopathic Orbital Inflammation Syndrome in Relation to Intraocular Pressure. Clinical Ophthalmology. 2022;16:1467-73.
Luk FOJ, Leung DYL, Yuen HKL, Lam DSC. Late leakage of filtering bleb in a patient with orbital pseudotumor. European Journal of Ophthalmology. 2006;16:611-3.
Moster MR. Trabeculectomy Postop: Staying on Track Review of Ophthalmology2013 [Available from: https://www.reviewofophthalmology.com/article/trabeculectomy-postop-staying-on-track-42261.
Caminha LSC, Pinto ER, Sousa PAMd, Oliveira RA, Conceiçao FL, Vaisman M. Orbital pseudotumor: a differential diagnosis of Graves' ophthalmopathy. Brazilian Archives of Endocrinology & Metabology. 2011;55(1).
Yuen S, Rubin P. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Archives of Ophthalmology. 2003;121(4):491-9.
Sharma SM, Choi D, Planck SR, Harrington CA, Austin CR, Lewis JA, et al. Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Research & Therapy. 2009;11(6):R168.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.